These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 18381476)

  • 21. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening.
    Ling BS; Schoen RE; Trauth JM; Wahed AS; Eury T; Simak DM; Solano FX; Weissfeld JL
    Arch Intern Med; 2009 Jan; 169(1):47-55. PubMed ID: 19139323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data sources for measuring colorectal endoscopy use among Medicare enrollees.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2118-27. PubMed ID: 17932360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening in young patients with poor health and severe comorbidity.
    Sultan S; Conway J; Edelman D; Dudley T; Provenzale D
    Arch Intern Med; 2006 Nov; 166(20):2209-14. PubMed ID: 17101938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer screening and surveillance: current standards and future trends.
    Martinez SR; Young SE; Hoedema RE; Foshag LJ; Bilchik AJ
    Ann Surg Oncol; 2006 Jun; 13(6):768-75. PubMed ID: 16604473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are there gender differences in colorectal cancer test use prevalence and correlates?
    McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence.
    Partin MR; Noorbaloochi S; Grill J; Burgess DJ; van Ryn M; Fisher DA; Griffin JM; Powell AA; Halek K; Bangerter A; Vernon SW
    Cancer Causes Control; 2010 Sep; 21(9):1357-68. PubMed ID: 20419343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):799-804. PubMed ID: 18381471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.